Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients

Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients

Sitagliptin and saxagliptin are oral hypoglycemic agents inhibitors of DPP-4, indicated in the treatment of type 2 diabetes mellitus in combination with metformin, in patients who have not achieved adequate glycemic control. In our study we enrolled 128 decompensated type 2 diabetes patients while o...

Full description

Bibliographic Details
Main Authors: Antonio Asti, Alessandra D'Alessandro, Francesco Paolo Zito, Salvatore Nardi, Giovanni Sarnelli, Giorgio Maresca, Giuseppe D’Alessandro
Format: Article
Language:English
Published: PAGEPress Publications 2016-03-01
Series:Italian Journal of Medicine
Subjects:
Type 2 diabetes mellitus
sitagliptin
saxagliptin
DPP-4 inhibitors.
Online Access:http://www.italjmed.org/index.php/ijm/article/view/558

Internet

http://www.italjmed.org/index.php/ijm/article/view/558

Similar Items